Low Risk vs High Risk MDS - What's the Difference?
58:34
Advances in Preventing and Treating GVHD
27:38
Treatment Decision-Making through the Spectrum of MDS
1:08:02
What every patient with myelodysplastic syndrome(s) should know 2018
18:54
Multiple Myeloma 101: Diagnosis, Prognosis, and Risk
1:28:26
Cancer Metabolism: From molecules to medicine
26:26
Myeloma 101: Diagnosis, Prognosis & Risk | Dana-Farber Cancer Institute
1:14:55
Strategies for Bone Medications with Dr. Benjamin Leder
43:19